Does SECUKINUMAB Cause Nephrolithiasis? 657 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 657 reports of Nephrolithiasis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.4% of all adverse event reports for SECUKINUMAB.
657
Reports of Nephrolithiasis with SECUKINUMAB
0.4%
of all SECUKINUMAB reports
14
Deaths
261
Hospitalizations
How Dangerous Is Nephrolithiasis From SECUKINUMAB?
Of the 657 reports, 14 (2.1%) resulted in death, 261 (39.7%) required hospitalization, and 19 (2.9%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 657 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which SECUKINUMAB Alternatives Have Lower Nephrolithiasis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG